New ways to treat bladder cancer improve survival and shake up the standard of care, new studies show – CNN

by

  1. New ways to treat bladder cancer improve survival and shake up the standard of care, new studies show CNN
  2. Merck, BMS Score Separate Late-Stage Victories in Bladder Cancer at ESMO BioSpace
  3. Seagen, Astellas post Phase 3 win for bladder cancer therapy (NASDAQ:SGEN) Seeking Alpha
  4. Frontline Enfortumab Vedotin Plus Pembrolizumab Elicits OS Improvement in Advanced Urothelial Carcinoma OncLive
  5. Groundbreaking EV-302 Trial Significantly Extends Overall Survival and Progression-Free Survival in Patients Treated with PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) in First-Line Advanced Bladder Cancer BioSpace
  6. View Full Coverage on Google News

Read original article here

Leave a Comment